NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
NAVCO Pharmaceuticals Inc. successfully concluded its Annual General Meeting, with all proposed resolutions passed, including the election of four directors and the appointment of a new auditor. Shareholders approved a new share option plan that aligns with updated TSX Venture Exchange policies and allows for cashless option exercises. The company, which specializes in nanotechnology-based products for combating various pathogens, continues to strengthen its market position in health and personal care sectors.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.